Demo Day 2013: Prommune
Channel: UNeMed Corporation
Date: 2013-11-26

Prommune Inc. is an early stage biotechnology company focused on the human and veterinary medicine applications of a novel therapeutic strategy for fighting infections by awakening the body's own natural immune defenses. Host-directed immunotherapy, or HDI, is induced by a structurally engineered peptide known as EP67. Prommune's EP67 selectively engages and activates the cell population responsible for innate immunity — the body's first line of defense against bacterial, viral and fungal infections.

On Oct. 7, 2013, UNeMed Corporation hosted its inaugural UNMC Startup Company Demonstration Day, bringing in seven companies formed on the basis of technologies developed and invented at the University of Nebraska Medical Center.